Table 3.
Variable | 1st treatment | Follow-up | |||
---|---|---|---|---|---|
pre | post 30 days | pre (follow-up) | post (follow-up) | ||
No relapse | PVC/day | 2034 (0 - 38804) | 264 (0 - 6677) | 7.3 (0 - 710) | NA* |
PsVC/day | 29.5 (0 - 19386) | 18.5 (0 - 15548) | 5.5 (0 - 973) | NA* | |
PC/hour | 119.9 (34.9 - 1616) | 15.5 (0 - 647.8) | 3 (0 - 40.5) | NA* | |
Relapse (N = 17) | PVC/day | 1386 (0 - 6497) | 3 (0 - 1616) | 1872 (0 - 8040) | 280 (0 - 3980) |
PsVC/day | 78 (0 - 20019) | 14 (0 - 13104) | 15 (0 - 12020) | 38 (0 - 7008) | |
PC/hour | 132 (21.1 - 839.7) | 10.3 (0 - 546) | 126.1 (33.4 - 511.3) | 50.2 (1 - 292) | |
Crossing (N = 21) | PVC/day | 3030 (0 - 22502) | 3002 (0 - 21429) | 2508 (0 - 22505) | 689 (0 - 18812) |
PsVC/day | 2 (0 - 15965) | 3 (0 - 19861) | 4 (0 - 15965) | 1 (0 - 10900) | |
PC/hour | 264.8 (32.5-938.2) | 299.3(34.6-899.6) | 264.8 (32.5 - 938.3) | 48 (0 - 784) |
Not applicable, PC: premature complexe; PVC: premature ventricular complexes; PsVC: premature supraventricular complexes.